Clinical Trial on Ladarixin Adjunctive Therapy to Improve Glycemic Control in Type 1 Diabetes.

Clinical trial NCT05368402 · TERMINATED

Trial details

NCT number: NCT05368402
Sponsor: Dompé Farmaceutici S.p.A
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Type 1 Diabetes

Start date: 2022-09-14
Primary completion: 2023-09-18
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.